Loading…
Data as of .
| Company | Industry | Market cap | 1M | 6M | Revenue growth | Op. margin | Fwd P/E |
|---|---|---|---|---|---|---|---|
| CSL CSL.AX | Biotechnology | $63.7B | +2% | +102% | -2% | 26% | 21.5× |
| Sigma Healthcare SIG.AX | Pharmaceuticals: Major | $22.4B | +2% | +2% | +209% | 9% | 38.4× |
| Pro Medicus PME.AX | Services to the Health Industry | $13.4B | +7% | +52% | +23% | 75% | 105.7× |
| Ramsay Health Care RHC.AX | Hospital/Nursing Management | $8.31B | -1% | +41% | +4% | 5% | 31.4× |
| Sonic Healthcare SHL.AX | Medical/Nursing Services | $6.87B | +7% | +6% | +14% | 9% | 17.4× |
| Cochlear COH.AX | Medical Specialties | $6.72B | +10% | +58% | -1% | 13% | 29.1× |
| Telix Pharmaceuticals TLX.AX | Biotechnology | $2.99B | -16% | -2% | +27% | -1% | 34.5× |
| EBOS EBO.AX | Medical Specialties | $2.50B | +10% | +7% | +3% | 3% | 15.7× |
| Neuren Pharmaceuticals NEU.AX | Pharmaceuticals: Generic | $1.87B | +13% | +52% | -68% | 20% | 36.5× |
| Mesoblast MSB.AX | Biotechnology | $1.49B | 0% | -17% | +556% | -43% | n/a |
| PYC Therapeutics PYC.AX | Pharmaceuticals: Major | $1.09B | -3% | +29% | n/a | n/a | n/a |
| Regis Healthcare REG.AX | Medical/Nursing Services | $962M | +1% | -28% | +17% | 4% | 25.3× |
| Nanosonics NAN.AX | Medical Specialties | $599M | -1% | -4% | +3% | 7% | 98.6× |
| Clarity Pharmaceuticals CU6.AX | Medical Specialties | $444M | +2% | -33% | n/a | n/a | n/a |
| Australian Clinical Labs ACL.AX | Medical/Nursing Services | $418M | +15% | +68% | -1% | 8% | 17.8× |
| Integral Diagnostics IDX.AX | Medical/Nursing Services | $413M | -22% | -22% | +26% | 9% | 14.7× |
| Polynovo PNV.AX | Biotechnology | $388M | -7% | -34% | +13% | 5% | 84.0× |
| Australian Unity Ltd Pref AYUPA.AX | Medical/Nursing Services | $352M | +11% | +17% | 0% | -2% | n/a |
| Mayne Pharma MYX.AX | Pharmaceuticals: Major | $333M | +139% | +155% | -6% | -14% | n/a |